These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration. Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD. Cruz-Gonzalez F; Cabrillo-Estévez L; López-Valverde G; Cieza-Borrella C; Hernández-Galilea E; González-Sarmiento R Graefes Arch Clin Exp Ophthalmol; 2014 Mar; 252(3):469-75. PubMed ID: 24522370 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes. Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082 [TBL] [Abstract][Full Text] [Related]
8. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration. Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050 [TBL] [Abstract][Full Text] [Related]
9. Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration. Muether PS; Hermann MM; Dröge K; Kirchhof B; Fauser S Am J Ophthalmol; 2013 Nov; 156(5):989-993.e2. PubMed ID: 23938122 [TBL] [Abstract][Full Text] [Related]
10. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point. Brown DM; Chen E; Mariani A; Major JC; Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab. Mathew R; Richardson M; Sivaprasad S Am J Ophthalmol; 2013 Apr; 155(4):720-6, 726.e1. PubMed ID: 23317653 [TBL] [Abstract][Full Text] [Related]